Edwards Lifesciences Corporation Faces Securities Lawsuit: How Affected Shareholders Can Take Action with The Schall Law Firm

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Edwards Lifesciences Corporation

About the Lawsuit

The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of a class action lawsuit against Edwards Lifesciences Corporation (“Edwards Lifesciences” or “the Company”) (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between February 6, 2024 and July

Leave a Reply